Plasma Levels of hsa-miR-619-5p and hsa-miR-1184 Differ in Prostatic Benign Hyperplasia and Cancer
- Authors: Knyazev E.N.1, Fomicheva K.A.2, Mikhailenko D.S.2, Nyushko K.M.2, Samatov T.R.1, Alekseev B.Y.2, Shkurnikov M.Y.1,2
-
Affiliations:
- BioClinicum Center Research and Development Company
- Medical Radiology Center
- Issue: Vol 161, No 1 (2016)
- Pages: 108-111
- Section: Article
- URL: https://journals.rcsi.science/0007-4888/article/view/237158
- DOI: https://doi.org/10.1007/s10517-016-3357-7
- ID: 237158
Cite item
Abstract
Peripheral blood plasma profiles of circulating microRNA expression were analyzed in patients with prostatic cancer and benign hyperplasia. In prostatic cancer, significant increase in hsa-miR-619-5p and hsa-miR-1184 microRNA expression and significant decrease in hsalet-7b-5p and hsa-let-7c-5p microRNA expression were observed. The role of the relationship between the microRNA expression and the activities and functions of host genes with introns encoding these microRNA is discussed.
About the authors
E. N. Knyazev
BioClinicum Center Research and Development Company
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
K. A. Fomicheva
Medical Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
D. S. Mikhailenko
Medical Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
K. M. Nyushko
Medical Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
T. R. Samatov
BioClinicum Center Research and Development Company
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
B. Ya. Alekseev
Medical Radiology Center
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow
M. Yu. Shkurnikov
BioClinicum Center Research and Development Company; Medical Radiology Center
Author for correspondence.
Email: mshkurnikov@imscs.msu.ru
Russian Federation, Moscow; Moscow